Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Main Authors:	Ilaria Romito, Manuela Porru, Maria Rita Braghini, Luca Pompili, Nadia Panera, Annalisa Crudele, Daniela Gnani, Cristiano De Stefanis, Marco Scarsella, Silvia Pomella, Stefano Levi Mortera, Emmanuel de Billy, Adrian Libenzio Conti, Valeria Marzano, Lorenza Putignani, Manlio Vinciguerra, Clara Balsano, Anna Pastore, Rossella Rota, Marco Tartaglia, Carlo Leonetti, Anna Alisi
Format:	Article
Language:	English
Published:	BMC 2022-01-01
Series:	Journal of Experimental & Clinical Cancer Research
Online Access:	https://doi.org/10.1186/s13046-022-02247-y

Internet